HSBC HOLDINGS PLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 127 filers reported holding NEKTAR THERAPEUTICS in Q4 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2024$95,948
+35.4%
75,8480.0%0.00%
Q1 2024$70,857
+68.3%
75,8480.0%0.00%
Q4 2023$42,096
-7.6%
75,8480.0%0.00%
Q3 2023$45,569
+5.4%
75,8480.0%0.00%
Q2 2023$43,249
-23.7%
75,848
-7.2%
0.00%
Q1 2023$56,670
-76.8%
81,704
-26.3%
0.00%
Q4 2022$244,530
-7.0%
110,900
+37.5%
0.00%
Q3 2022$263,000
+62.3%
80,667
+88.2%
0.00%
Q2 2022$162,000
+36.1%
42,858
+95.7%
0.00%
Q1 2022$119,000
-47.6%
21,895
+32.2%
0.00%
Q4 2021$227,000
-44.6%
16,568
-30.1%
0.00%
Q2 2021$410,000
+26.9%
23,712
+22.6%
0.00%
-100.0%
Q3 2020$323,000
-14.3%
19,334
+18.7%
0.00%0.0%
Q2 2020$377,000
-69.4%
16,287
-75.9%
0.00%
-50.0%
Q3 2019$1,233,000
-54.4%
67,643
-11.1%
0.00%
-60.0%
Q2 2019$2,706,000
+16.4%
76,050
+9.9%
0.01%
+25.0%
Q1 2019$2,324,000
+42.4%
69,171
+39.3%
0.00%
+33.3%
Q4 2018$1,632,000
-57.5%
49,656
-22.3%
0.00%
-50.0%
Q3 2018$3,841,000
+39.3%
63,916
+13.1%
0.01%
+20.0%
Q2 2018$2,758,000
-82.6%
56,499
-62.1%
0.01%
-79.2%
Q1 2018$15,828,000
+4272.4%
148,960
+404.7%
0.02%
+2300.0%
Q4 2016$362,000
+162.3%
29,512
+167.4%
0.00%
Q2 2015$138,000
+14.0%
11,035
+0.7%
0.00%
Q1 2015$121,000
-33.5%
10,959
-6.4%
0.00%
Q4 2014$182,00011,7140.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2023
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders